IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery

S196 The present and the future of toxins: what's new

samedi 28 janvier 2023

14:00 to 15:30

Amphi Bleu - Level 2

SESSION SCIENTIFIQUE

Modérateur(s)

Dr Benjamin ASCHER

Chirurgien Plasticien

France

Dr Philippe PICAUT

PhD - Chercheur

France

Présentations de la session

14:00

Introduction by the chairs

14:02

Dr Philippe PICAUT

Toxins overview: 2023 update

14:10

Dr Michael CECERLE

LetibotulinumtoxinA: what’s new 1 year after approval? (Croma)

14:10

Part 1 - Future botulinum toxins to arrive on the European market

14:18

Dr Rui AVELAR

Prabotulinumtoxin longer duration formulation first interim analysis (Evolus)

14:26

Dr Conor GALLAGHER

DaxibotulinumtoxinA for injection: the new FDA-approved long lasting botulinum toxin formulation (Revance)

14:34

Panel discussion

14:49

Part 2 - Novel botulinum toxins

14:49

Mickael MACHICOANE

How to boost your usual toxin performance? (Fastox)

14:57

Xiaoming LIN

RelabotulinumtoxinA: proprietary strain and liquid manufacturing process for a novel long-lasting neuromodulator (Galderma)

15:05

Jon EDELSON

ET-01 – A phase 2b topical botulinum product candidate (Eirion)

15:13

Panel discussion

Sessions à ne pas manquer

IMCAS Alert - Injectables S175

Biostimulation by fillers S209

Anatomy on Cadaver Workshop - Lower face & body S005, S006

Symposium de l'industrie

ALLERGAN AESTHETICS Symposium - Your 360°: no gender agenda S194, S195

Symposium de l'industrie

ACROSS Symposium - Reaching new horizons in facial harmony with Revolax™ dermal filler: advanced triple combination treatment (Revolax™ + BoNT + thread lifting) strategy meets optimized beautification S085

Vous avez une question ?

Attention

Modérateur(s)

Présentations de la session

Sessions à ne pas manquer

Vous avez une question ?

Erreur